Aktis Oncology Announces $72M Series A Financing To Advance Breakthrough Radiopharmaceuticals To Treat Solid Tumors

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3eV6pL1
via IFTTT